Profilo
Elmar Schärli is currently the Director at Zilentin AG and the Chief Financial Officer at Xigen SA. Previously, he worked as the Chief Financial Officer at Altamira Therapeutics Ltd.
from 2019 to 2021.
Posizioni attive di Elmar Schärli
| Società | Posizione | Inizio |
|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Director of Finance/CFO | - |
Zilentin AG
 Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Director/Board Member | - |
Precedenti posizioni note di Elmar Schärli
| Società | Posizione | Fine |
|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Director of Finance/CFO | 01/11/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Elmar Schärli
